SEMAGLUTIDE·LOUISIANA·VERIFIED MAY 13, 2026

Is Semaglutide legal in Louisiana?

CAVEATS APPLY

FDA-approved GLP-1 receptor agonist (Ozempic/Wegovy/Rybelsus); shortage resolved Feb 2025; compounded copies broadly restricted; FDA Warning Letters target salt-form variants and counterfeit sema. Louisiana Board of Pharmacy explicit cease-and-desist for in-state compounding pharmacies on semaglutide salt-form variants; out-of-state 503Bs barred from shipping into LA.

CATEGORY · FDA APPROVED

Full status breakdown

FEDERAL · STATE · SPORT-BODY

Federal status

FDA approval

approved as drug · brand: Ozempic, Wegovy, Rybelsus · NDA 209637 (Ozempic); NDA 213051 (Rybelsus); NDA 215256 (Wegovy) · approved Dec 5, 2017

Indications: T2DM; chronic weight management; CV risk reduction; MASH

FDA SOURCE ↗

DEA scheduling

not scheduled

DEA ORANGE BOOK ↗

503A compounding

Bulks list: not on list

Do-not-compound list: not on list

Approved drug; post-shortage compounding of essentially-copies restricted under §503A. 503A enforcement discretion ended Apr 22, 2025; 503B May 22, 2025. FDA proposed April 2026 exclusion from 503B bulks list.

SOURCE ↗

FDA Warning Letters

Feb 7, 2024 — US Chem Labs (cited: semaglutide) · LETTER ↗
Sep 9, 2025 — SemaBio (cited: semaglutide) · LETTER ↗
Sep 9, 2025 — Hims & Hers (Hers) (cited: semaglutide) · LETTER ↗
Feb 20, 2026 — Better Health Labs dba Measured (cited: semaglutide) · LETTER ↗

Shortage status

not currently on shortage list

Historical shortage window: Jan 1, 2022 → Feb 21, 2025

SOURCE ↗

Sale framing

Research-use-only posture: RUO does not protect sellers when site evidence shows human-use intent. FDA has flagged salt-form variants of compounded semaglutide as distinct from the approved drug.

Personal possession: Not federally controlled; personal possession is not a federal crime. Approved sema is Rx-only and dispensing without prescription violates federal and state pharmacy law.

SOURCE 1 ↗

Louisiana — state-specific

compounding restriction · Louisiana

Louisiana Board of Pharmacy explicit cease-and-desist for in-state compounding pharmacies on semaglutide salt-form variants; out-of-state 503Bs barred from shipping into LA.

Louisiana Illuminator — LBP guidance ↗ · verified May 13, 2026

Sport-body status

WADA 2026

on prohibited list · class S2 · both

S2 (Peptide hormones); GLP-1 receptor agonist captured by class language.

WADA LIST ↗

USADA

banned

SOURCE ↗

NCAA

banned

SOURCE ↗

What we couldn’t verify

Also known as

9 ALIASES

Semaglutide is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):

Ozempic
Wegovy
Rybelsus
Sema
Sema-1
GLP-1 receptor agonist
NDA 209637
NDA 213051
NDA 215256

FOLLOW-ONS

Back to peptide legality lookup — pick a different compound or state
Semaglutide research guide — mechanism, dosing math, vendor audits, COA data
Peptide pricing index — what each compound costs per mg across audited vendors
Janoshik COA verifier — a separate question from legality: does the COA the vendor cites actually exist?

Semaglutide legality in other US states

State-by-state legal status for the same compound. Federal classification holds, state law varies.

Is Semaglutide legal in Louisiana?

Full status breakdown

Federal status

Louisiana — state-specific

Sport-body status

What we couldn’t verify

Also known as

Related

Semaglutide legality in other US states

Receipts in your inbox. Once a month.